Champions

CSBR NASDAQ
7.87
+0.22
+2.88%
盘后: 7.61 -0.26 -3.30% 16:00 07/17 EDT
开盘
7.65
昨收
7.65
最高
7.94
最低
7.65
成交量
2.28万
成交均量(3M)
2.83万
52周最高
17.90
52周最低
5.98
换手率
0.20%
市值
9,059.91万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Champions CSBR股票价格,Champions股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans. The TOS segment provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. Its TumorGraft Technology Platform consists of processes, physical tumors and information that it uses to personalize the development and use of oncology drugs. Each tumor from patients that it has preserved for implantation in mice, along with the patient data and molecular information associated with the tumors, are known as TumorGrafts or Patient Derived XenoGrafts of PDX Models. The collection of TumorGrafts is referred to as the Company's TumorBank.
展开 >

最近浏览

名称
价格
涨跌幅